item management s discussion and analysis of financial condition and results of operations the following discussion and analysis should be read in conjunction with selected consolidated financial data and the company s consolidated financial statements and notes thereto included elsewhere in this report 
in addition to the historical information contained herein  the discussions in this report may contain forward looking statements that involve risks and uncertainties 
the company s actual results could differ materially from those discussed herein 
overview the company provides a broad range of services and value added products focused on chemical analysis to the worldwide pharmaceutical  medical device and biotechnology industries 
the company s customer focused approach and high quality products and services enable it to serve as a value added partner in solving complex scientific problems by providing cost effective results to its customers on an accelerated basis 
founded in in lansing  michigan and relocated to west lafayette  indiana in  the company has experienced growth primarily through internal expansion  supplemented by strategic acquisitions 
as part of its internal growth strategy  the company has developed technical specialties in such areas as chromatography  electrochemistry  in vivo sampling and mass spectrometry 
the company s growth has strategically positioned it to take advantage of globalization in the marketplace and to provide new services and areas of technical expertise to its customers 
during this phase  the company has been continuously profitable since throughout its history  the company has taken steps to position itself as a global leader in the analytical chemistry field 
development of the company s infrastructure began in when it established relationships with several customers and multiple international distributors 
in  the company increased its sphere of influence to include japan with the creation of bas japan  an independent distributor 
in  the company enhanced its computer software expertise by acquiring interactive microware  inc in state college  pennsylvania 
in  the company began offering contract services to customers that lacked the time or expertise to perform certain analyses using the company s analytical products 
in  the company acquired a distributor  bas instruments ltd  to further solidify its presence in the united kingdom 
in  the company acquired a manufacturer of veterinary monitoring and diagnostic equipment  bas vetronics  to provide additional preclinical support 
in  the company also acquired a contract services firm  bas analytics ltd  to offer local service in the united kingdom 
revenues are derived principally from i analytical services provided to customers and ii the sale of the company s analytical instruments and other products 
both methods of generating revenue utilize the company s ability to identify  isolate and resolve client problems relating to the separation and quantification of individual substances in complex mixtures 
the company supports the pharmaceutical industry by focusing on analytical chemistry for biomedical research  diagnostics  electrochemistry and separations science 
the company s analytical products are sold primarily to pharmaceutical firms and research organizations 
principal customers include scientists engaged in drug metabolism studies  as well as those engaged in basic neuroscience research 
the company was the first to commercialize the liquid chromatograph and electrochemistry technology which is now the worldwide standard for the determination of neurotransmitter substances 
research products include in vivo sampling devices  reagent chemicals  electrochemical apparatus and sensors 
the company s pharmaceutical service contracts generally have terms ranging from several months to several years 
a portion of the contract fee is generally payable upon receipt of the initial samples with the balance payable in installments over the life of the contract  and the contracts are broken down into discrete units of deliverable services for which a fixed fee per unit is established 
revenue and related direct costs are recognized as specific contract terms are fulfilled under the percentage of completion method utilizing units of delivery 
the termination of a contract results in no material adjustments to revenue or direct costs previously recognized  and the company is entitled to payment for all work performed through the date of notice of termination and all costs associated with termination of a contract 
revenue from the sale of the company s products and the related costs are recognized upon shipment of the products to customers 
the company s management believes that fluctuations in the company s quarterly results are caused by a number of factors  including the company s success in attracting new business  the size and duration of service contracts  the timing of its clients decisions to enter into new contracts  the cancellation or delays of on going contracts  the timing of acquisitions and other factors  many of which are beyond the company s control 
in fiscal  approximately of the company s total revenue was derived from customers located outside the united states 
these markets tend to be much more volatile than the united states market 
significant governmental  regulatory  political  economic and cultural issues or changes could adversely affect the growth or profitability of the company s business activities in any such market 
results of operations the following table sets forth  for the periods indicated  certain statement of income data as a percentage of total revenue 
percentage of revenue year ended september  services revenue product revenue total revenue cost of services revenue cost of product revenue total cost of revenue gross profit operating expenses selling research and development general and administrative total operating expenses operating income other income expense  net income before income taxes income taxes net income year ended september  compared with year ended september  total revenue for the year ended september  increased to million from million in the year ended september  the net increase of million related primarily to increased revenue from services  which increased to million in the year ended september  from million in the year ended september  as a result of the expansion of the types and volume of services provided by the company 
during this same period  product revenue decreased to million for the year ended september  from million for the year ended september  primarily as a result of decreased sales in the asian electrochemistry markets 
costs of revenue increased to million for the year ended september  from million for the year ended september  this increase of million was largely due to the addition of a uk services facility 
costs of revenue for the company s services increased to as a percentage of services revenue for the year ended september  from of services revenue for the year ended september  due to an increase in services support staff 
costs of revenue for the company s products increased to as a percentage of product revenue for the year ended september  from of product revenue for the year ended september   due primarily to a change in product mix 
selling expenses for the year ended september  decreased to million from million during the year ended september  due to decreased foreign commission expense 
research and development expenses for the year ended september  decreased to million from million for the year ended september  due to the decrease in research grant activity 
general and administrative expenses for the year ended september  increased to million from million for the year ended september   primarily as a result of an increase in administrative staff expense and an increase in health care costs 
other income expense  net  was  in the year ended september  as compared to  in the year ended september  as a result of the increase in interest expense due to an increase in long term debt 
the company s effective tax rate for was as compared to for fiscal this decrease was primarily due to a decrease in nondeductible foreign losses incurred in fiscal year ended september  compared with year ended september  total revenue for the year ended september  increased to million from million in the year ended september  the net increase of million related primarily to increased revenue from services  which increased to million in the year ended september  from million in the year ended september  as a result of the expansion of the types and volume of services provided by the company 
during this same period  product revenue increased to million for the year ended september  from million for the year ended september  primarily as a result of increased penetration in the physiology and the liquid chromatography markets 
costs of revenue increased to million for the year ended september  from million for the year ended september  this increase of million was largely due to the hiring of support staff in the services unit 
costs of revenue for the company s services increased to as a percentage of services revenue for the year ended september  from of services revenue for the year ended september  due to an increase in services support staff 
costs of revenue for the company s products increased to as a percentage of product revenue for the year ended september  from of product revenue for the year ended september   due primarily to a change in product mix 
selling expenses for the year ended september  increased to million from million during the year ended september  due to increased salary expense 
research and development expenses for the year ended september  increased to million from million for the year ended september  due to the increase in research grant activity 
general and administrative expenses for the year ended september  increased to million from million for the year ended september   primarily as a result of increased legal expenses associated with the patent infringement suit 
see item legal proceedings other income expense  net  was  in the year ended september  as compared to  in the year ended september  as a result of the increase in interest income due to an increase in cash and cash equivalents resulting from the initial public offering 
the company s effective tax rate for was as compared to for fiscal this increase was primarily due to nondeductible foreign losses incurred in fiscal liquidity and capital resources since its inception  the company s principal sources of cash have been cash flow generated from operations and funds received from bank borrowings and other financings including the company s initial public offering completed in november at september   the company had cash and cash equivalents of million  compared to cash and cash equivalents of million at september  the increase in cash resulted primarily from the increase in debt which partially funded the increase in capital expenditures made to expand the company s facilities and operations 
the company s net cash provided by operating activities was million for the year ended september  cash provided by operations during the year ended september  consisted of net income of  plus non cash charges of  less a net increase of  in operating assets and liabilities 
the most significant increase in operating assets related to trade accounts receivable  which increased  at september  cash used by investing activities decreased to million for the year ended september  from million for the year ended september   primarily as a result of the company s completed construction of additional facilities 
cash provided by financing activities for fiscal was million due to the increase in debt 
the company s net cash provided by operating activities was million for the year ended september  cash provided by operations during the year ended september  consisted of net income of  plus non cash charges of  plus a net decrease of  in operating assets and liabilities 
the most significant decrease in operating assets related to trade accounts receivable  which decreased  at september  cash used by investing activities increased to million for the year ended september  from million for the year ended september   primarily as a result of the company s purchase and construction of additional facilities  as well as the acquisition of clinical innovations bas analytics  ltd 
cash provided by financing activities for fiscal was million due to the initial public offering partially offset by the reduction of debt 
total expenditures by the company for property and equipment were million  million and million in fiscal  and  respectively 
expenditures made in connection with the expansion of the company s operating facilities and purchases of laboratory equipment account for the largest portions of these expenditures 
the increased capital investments relate to the completion of the renovation and construction of additional facilities and the purchase of additional laboratory equipment corresponding to anticipated increases in research services to be provided by the company 
the company expects to make other investments to expand its operations through internal growth  strategic acquisitions  alliances and joint ventures 
however  the company currently has no firm commitments for capital expenditures 
based on its current business activities  the company believes that cash generated from its operations  amounts available under its existing bank lines of credit and credit facility and the remaining net proceeds from its initial public offering will be sufficient to fund the company s working capital and capital expenditure requirements for the foreseeable future 
the company has a working capital line of credit  which expires april  and allows borrowings of up to  interest accrues monthly on the outstanding balance at the bank s prime rate minus basis points at september  or at the london interbank offered rate libor plus as elected by the company 
the line is collateralized by inventories and accounts receivable and requires the company to maintain certain financial ratios 
there was no balance outstanding on this line of credit at september  the company has an acquisition line of credit agreement  which expires april  and allows borrowings of up to  interest accrues monthly on the outstanding balance at the bank s prime rate at september  
there was no balance outstanding on this line of credit at september on june  the company obtained a  commercial mortgage with a bank 
the mortgage note requires monthly principal payments of  plus interest followed by a final payment for the unpaid principal amount of  due june  interest is charged at the one month libor rate plus basis points at september  
inflation the company believes that inflation has not had a material adverse effect on its business  operations or financial condition 
year the company undertook in fiscal to identify information technology and other systems which may not be year compliant 
the company has modified its computer hardware and software systems to recognize the year management has contacted significant suppliers  customers and financial institutions to ensure that those parties have appropriate plans to remediate year issues where their systems interface with the company s systems or impact its operations 
the company is also assessing the effect on its operations should those organizations fail to properly remediate their computer systems 
the cost of the year initiatives is not expected to be material to the company s results of operations or financial position 
new accounting pronouncements effective october   the company adopted the provisions of statement of financial accounting standards no 
sfas no 
 disclosures about segments of an enterprise and related information 
sfas no 
establishes standards for the way that public enterprises report information about operating segments in annual financial statements and requires that those enterprises report selective information about operating segments in interim financial reports 
sfas no 
also establishes standards about products and services  geographic areas and major customers 
the adoption of sfas no 
did not affect results of operations or financial position  but did affect the disclosure of segment information 
effective october   the company adopted the provisions of statement of financial accounting standards no 
sfas no 
 reporting comprehensive income  which requires entities to report comprehensive income in their financial statements 
comprehensive income refers to the change in an entity s equity during a period resulting from all transactions and events other than capital contributed by and distributions to the entity s owners 
for the company  comprehensive income is equal to net income adjusted for the change in currency translation 
the company has elected to report comprehensive income in the consolidated statements of shareholders equity 
the company s prior years financial statements have been reclassified for comparative reporting purposes  however  there was no change in the net income or total shareholders equity previously reported for the years ended september  and item a 
quantitative and qualitative disclosures about market risk not applicable 

